[ Price : $8.95]
Consumers for Dental Choice and two other advocacy groups again petition FDA to ban the use of mercury amalgams in dentistry, espe...[ Price : $8.95]
FDA approves a Regeneron Pharmaceuticals BLA for Otarmeni (lunsotogene parvec-cwha), the first gene therapy for a form of inherite...[ Price : $8.95]
FDA commissioner Marty Makary says the agency is not planning to eliminate direct-to-consumer pharmaceutical advertising, even as ...[ Price : $8.95]
Researchers describe FDA and congressional actions that will improve the ability of the new plausible mechanism pathway to lead to...[ Price : $8.95]
Gilead calls on FDA to rescind its decision to file a Cipla 505(b)(2) NDA for an apparent duplicate of Gileads Descovy.[ Price : $8.95]
FDA issues a Warning Letter to New Life Pharma citing serious manufacturing and regulatory violations tied to the companys product...[ Price : $8.95]
FDA extends by three months its review of a Sanofi BLA for a subcutaneous formulation of Sarclisa (isatuximab-irfc) for use in com...[ Price : $8.95]
FDA releases the form FDA-483 issued following an inspection at the Vet4U drug distribution facility in Clay, NY.